DuPont Delivers 3Q 2013 Operating Earnings of $.45 per Share

         DuPont Delivers 3Q 2013 Operating Earnings of $.45 per Share

Sales Increase on Higher Volume

PR Newswire

WILMINGTON, Del., Oct. 22, 2013

WILMINGTON, Del., Oct. 22, 2013 /PRNewswire/ -- DuPont today announced third
quarter 2013 operating earnings of $.45 per share compared to $.43 per share
in the prior year. GAAP^1 earnings from continuing operations were $.28 per
share versus a loss of $.05 per share for the third quarter 2012. Third
quarter results principally reflect overall top-line growth and earnings
improvements for Performance Materials, Electronics & Communications and
Safety & Protection, and a lower effective tax rate. This was offset by
expected lower earnings for Performance Chemicals.

Highlights

  oThird quarter net sales of $7.7 billion increased 5 percent, with volume
    up 9 percent versus a weak prior year. Sales also reflect 3 percent lower
    local prices and a 1 percent negative currency impact.
  oExcluding Performance Chemicals, all operating segments posted increased
    operating earnings versus last year. Performance Materials, Electronics &
    Communications, Safety & Protection and Industrial Biosciences had
    double-digit earnings growth reflecting higher volumes and improved
    margins.
  oAgriculture sales grew 15 percent driven by increased insecticide volumes
    and higher seed prices in Latin America. The sales growth and the benefit
    of increased ownership in Pannar Seed (Pty) Ltd. reduced the segment's
    third quarter seasonal loss to $62 million.
  oCost productivity gains and restructuring savings are on track to meet or
    exceed full-year targets.
  oThe company continues to expect full-year operating earnings of about
    $3.85 per share.

"We executed well against our plans. Third quarter sales volumes and
operating earnings were stronger across most businesses compared to a soft
quarter last year," said DuPont Chair and CEO Ellen Kullman. "While we expect
overall sequential growth in industrial market demand will remain subdued,
fourth quarter operating earnings will be up substantially from last year.
For the full year we are on track to deliver modest earnings growth, despite
the significant decline in Performance Chemicals'results."

^1Generally Accepted Accounting Principles (GAAP)

Global Consolidated Net Sales – 3rd Quarter

Third quarter 2013 net sales were $7.7 billion, up 5 percent versus last year,
reflecting 9 percent higher volume, partly offset by 3 percent lower local
selling prices and 1 percent negative currency impact. The table below shows
third quarter regional sales and variances versus third quarter 2012.



                      Three Months Ended
                                          Percentage Change Due to:
                      September 30, 2013
(Dollars in           $         % Change  Local  Currency  Volume  Portfolio/
millions)                                 Price   Effect            Other
U.S. & Canada         $       3         (1)     -         5       (1)
                      2,548
EMEA*                 1,814     10        (5)     2         10      3
Asia Pacific          1,944     3         (6)     (3)       12      -
Latin America         1,429     4         -       (4)       8       -
Total Consolidated    $       5         (3)     (1)       9       -
Sales                 7,735
* Europe, Middle East & Africa



Segment Sales – 3rd Quarter

The table below shows third quarter 2013 segment sales with related variances
versus the prior year.



SEGMENT SALES                 Three Months Ended     Percentage Change
(Dollars in millions)         September 30, 2013     Due to:
                                                     USD            Portfolio/
                              $            % Change         Volume
                                                     Price          Other
Agriculture                   $   1,633  15        1      10      4
Electronics & Communications 638          5         (9)    14      -
Industrial Biosciences        305          4         -      4       -
Nutrition & Health            868          (1)       1      (1)     (1)
Performance Chemicals         1,720        (1)       (13)   12      -
Performance Materials         1,663        3         (2)    6       (1)
Safety & Protection           985          5         -      5       -
Other                         1            nm
Total segment sales           7,813
Elimination of transfers      (78)
Consolidated net sales        $   7,735



Operating Earnings – 3rd Quarter



                                                            Change vs. 2012
(Dollars in millions)             3Q13         3Q12         $             %
Agriculture                      $         $   (70)  $        11%
                                  (62)                      8
Electronics & Communications      97           58           39            67%
Industrial Biosciences            45           40           5             13%
Nutrition & Health                81           77           4             5%
Performance Chemicals             254          413          (159)         -38%
Performance Materials             374          331          43            13%
Safety & Protection               171          147          24            16%
Other                             (112)        (85)         (27)          nm
                                  848          911          (63)          -7%
Pharmaceuticals                  5            10           (5)           -50%
Total segment operating earnings  853          921          (68)          -7%
^(1)
Corporate expenses                (162)        (174)        12            nm
Interest expense                  (108)        (116)        8             nm
Operating earnings before income  583          631          (48)          -8%
taxes and exchange gains/losses
Provision for income taxes on
operating earnings, excluding     (111)        (164)        53            nm
taxes
 on exchange gains/losses
Net after-tax exchange gains      (43)         (59)         16            nm
(losses) ^(2)
Net income attributable to        (3)          (3)          -             nm
noncontrolling interests
Operating earnings              $    426  $   405   $     21  5%
Operating earnings per share      $   0.45  $   0.43   $   0.02   5%
(1) See Schedules B and C for listing of significant items and their impact
by segment.
(2) See Schedule D for additional information on exchange gains and losses.



The following is a summary of business results for each of the company's
reportable segments in the third quarter comparing the current quarter with
the prior year. References to selling price are on a U.S. dollar basis,
including the impact of currency.

Agriculture – A seasonal operating loss of $62 million improved $8 million.
The improvement was driven by strong insecticide demand as growers anticipate
heavy insect pressure in Latin America, price improvement in seeds, and a $26
million gain resulting from the acquisition of a controlling interest in
Pannar. These increases were offset by higher seed costs reflecting
finalization of the northern hemisphere season, continued investment to drive
future growth and a negative currency impact.

Electronics & Communications – Operating earnings of $97 million increased $39
million driven by higher sales volume, mainly in photovoltaic markets
reflecting demand improvement and share gains. Higher volume was offset in
part by reduced selling prices, mainly from pass-through of lower metals
prices.

Industrial Biosciences – Operating earnings of $45 million were up 13 percent
on higher sales of Sorona^®polymer for carpeting and apparel and lower costs,
partially offset by higher raw material costs.

Nutrition & Health –  Operating earnings of $81 million increased 5 percent
reflecting productivity improvements, partially offset by higher cost guar
inventory and negative currency.

Performance Chemicals – Operating earnings of $254 million were $159 million
lower as price declines for titanium dioxide, refrigerants and fluoropolymers,
along with higher raw material inventory costs, principally ore costs, more
than offset volume increases. Titanium dioxide volume was up 25 percent from
third quarter 2012 and essentially flat on a sequential basis.

Performance Materials – Operating earnings of $374 million increased $43
million including a $30 million benefit from a joint venture. Earnings
improvement from higher volume reflecting increased demand in packaging,
automotive, and electronics markets was partially offset by lower selling
prices.

Safety & Protection – Operating earnings of $171 million increased $24 million
due primarily to higher volume and productivity improvements, partially offset
by weaker sales mix. Higher volume reflects increased demand for U.S.
ballistics military protection, protective garments, and construction products
that offset softness in global public sector spending.

Additional information is available on the DuPont Investor Center website at
http://www.investors.dupont.com.

Outlook

The company continues to expect full-year operating earnings of about $3.85
per share, with some changes in underlying assumptions. The company now
anticipates slightly lower full-year growth rates for global GDP and
industrial production, a larger negative currency impact and a lower base tax
rate of about 22 percent.

Use of Non-GAAP Measures

Management believes that certain non-GAAP measurements are meaningful to
investors because they provide insight with respect to ongoing operating
results of the company. Such measurements are not recognized in accordance
with GAAP and should not be viewed as an alternative to GAAP measures of
performance. Reconciliations of non-GAAP measures to GAAP are provided in
schedules A, C and D.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the
global marketplace in the form of innovative products, materials, and services
since 1802. The company believes that by collaborating with customers,
governments, NGOs, and thought leaders we can help find solutions to such
global challenges as providing enough healthy food for people everywhere,
decreasing dependence on fossil fuels, and protecting life and the
environment. For additional information about DuPont and its commitment to
inclusive innovation, please visit http://www.dupont.com.

Forward-Looking Statements: This news release contains forward-looking
statements which may be identified by their use of words like "plans,"
"expects," "will," "believes," "intends," "estimates," "anticipates" or other
words of similar meaning. All statements that address expectations or
projections about the future, including statements about the company's growth
strategy, product development, regulatory approval, market position,
anticipated benefits of acquisitions, outcome of contingencies, such as
litigation and environmental matters, expenditures and financial results, are
forward-looking statements. Forward-looking statements are not guarantees of
future performance and are based on certain assumptions and expectations of
future events which may not be realized. Forward-looking statements also
involve risks and uncertainties, many of which are beyond the company's
control. Some of the important factors that could cause the company's actual
results to differ materially from those projected in any such forward-looking
statements are: fluctuations in energy and raw material prices; failure to
develop and market new products and optimally manage product life cycles;
significant litigation and environmental matters; failure to appropriately
manage process safety and product stewardship issues; changes in laws and
regulations or political conditions; global economic and capital markets
conditions, such as inflation, interest and currency exchange rates; business
or supply disruptions; security threats, such as acts of sabotage, terrorism
or war, weather events and natural disasters; ability to protect and enforce
the company's intellectual property rights; and successful integration of
acquired businesses and separation of underperforming or non-strategic assets
or businesses. The company undertakes no duty to update any forward-looking
statements as a result of future developments or new information.



E. I. du Pont de Nemours and Company

Consolidated Income Statements

(Dollars in millions, except per share amounts)
SCHEDULE A
               Three Months Ended        Nine Months Ended
               September 30,             September 30,
               2013         2012         2013         2012
Net sales      $       $       $        $    
               7,735        7,390       27,987       27,487
Other income
(loss),        70           (54)         321          251
net^(a)
Total          7,805        7,336        28,308       27,738
Cost of goods  5,165        4,779        17,415       16,558
sold
Other
operating      990          937          2,843        3,064
charges ^(a)
Selling,
general and    774          764          2,740        2,691
administrative
expenses
Research and
development    540          521          1,603        1,562
expense
Interest       108          116          340          347
expense
Employee
separation /
asset related  -            394          -            394
charges, net
^(a)
Total          7,577        7,511        24,941       24,616
Income (loss)
from
continuing     228          (175)        3,367        3,122
operations
before income
taxes
(Benefit from)
provision for
income taxes   (35)         (135)        687          654
on continuing
operations
^(a)
Income from
continuing
operations     263          (40)         2,680        2,468
after income
taxes
Income from
discontinued   25           48           1,997        219
operations
after taxes
Net income    288          8            4,677        2,687
Less: Net
income
attributable   3            3            14           24
to
noncontrolling
interests
Net income     $       $       $       $     
attributable    285           5    4,663        2,663
to DuPont
Basic earnings
per share of
common stock
^(b):
Basic earnings
(loss) per
share of       $       $       $       $     
common stock    0.28       (0.05)       2.87        2.61
from
continuing
operations
Basic earnings
per share of
common stock   0.03         0.05         2.16         0.24
from
discontinued
operations
Basic earnings $       $       $       $     
per share of    0.30           -     5.03        2.85
common stock
Diluted
earnings per
share of
common stock
^(b):
Diluted
earnings
(loss) per
share of       $       $       $       $     
common stock    0.28       (0.05)       2.85        2.58
from
continuing
operations
Diluted
earnings per
share of
common stock   0.03         0.05         2.14         0.23
from
discontinued
operations
Diluted
earnings per   $       $       $       $     
share of        0.30           -     4.99        2.82
common stock
Dividends per
share of       $       $       $       $     
common          0.45        0.43       1.33        1.27
stock
Average number
of shares
outstanding
used in
earnings per
share (EPS)
calculation:
 Basic        925,645,000  931,737,000  925,548,000  933,227,000
 Diluted      933,005,000  940,526,000  932,542,000  942,524,000
(a) See
Schedule B for
detail of
significant
items.
(b) The sum of
the individual
earnings per
share amounts
may not equal
the total due
to rounding.
Reconciliation
of Non-GAAP
Measures
Summary of
Earnings
Comparison
               Three Months Ended                     Nine Months Ended
               September 30,                          September 30,
               2013         2012         %            2013         2012    %
                                         Change                            Change
Income from
continuing     $       $                    $       $  
operations      263         (40)     758%         2,680       2,468  9%
after income
taxes (GAAP)
Less:
Significant
items benefit
(charge)
included in
income from
continuing
operations
after income   (71)         (342)                     (129)        (589)
taxes (per
Schedule B)

Non-operating
pension/OPEB
costs included
in income
from
continuing
operations     (95)         (106)                     (279)        (340)
after income
taxes
 Net income
attributable
to             3            3                         14           24
noncontrolling
interest
Operating      $       $       5%           $       $     -9%
earnings       426         405                   3,074       3,373
EPS from                                                           $  
continuing     $       $       660%         $              10%
operations      0.28       (0.05)                    2.85      2.58
(GAAP)
Significant
items benefit
(charge)       (0.08)       (0.37)                    (0.14)       (0.63)
included in
EPS (per
Schedule B)
Non-operating
pension/OPEB   (0.09)       (0.11)                    (0.30)       (0.36)
costs included
in EPS
               $       $                    $       $  
Operating EPS   0.45        0.43      5%            3.29             -8%
                                                                   3.57



E. I. du Pont de Nemours and Company

Condensed Consolidated Balance Sheets

(Dollars in millions, except per share amounts)
SCHEDULE A (continued)
                                         September30,     December 31,

                                         2013               2012
Assets
Current assets
Cash and cash equivalents                $      7,005  $      4,284
Marketable securities                    184                123
Accounts and notes receivable, net      8,298              5,452
Inventories                             7,031              7,565
Prepaid expenses                         185                204
Deferred income taxes                   840                613
Assets held for sale                     -                  3,076
Total current assets                     23,543             21,317
Property, plant and equipment, net of
accumulated depreciation                 12,908             12,741
 (September 30, 2013 - $19,779;
December 31, 2012 - $19,085)
Goodwill                                 4,718              4,616
Other intangible assets                 5,135              5,126
Investment in affiliates                 1,054              1,163
Deferred income taxes                   3,739              3,936
Other assets                             893                960
Total                                    $     51,990   $     49,859
Liabilities and Equity
Current liabilities
Accounts payable                         $      3,876  $      4,853
Short-term borrowings and capital lease  4,204              1,275
obligations
Income taxes                            442                343
Other accrued liabilities                3,874              5,997
Liabilities related to assets held for   -                  1,084
sale
Total current liabilities                12,396             13,552
Long-term borrowings and capital lease   10,755             10,465
obligations
Other liabilities                        13,901             14,687
Deferred income taxes                    973                856
Total liabilities                        38,025             39,560
Commitments and contingent liabilities
Redeemable noncontrolling interest       65                 -
Stockholders' equity
Preferred stock                          237                237
Common stock, $0.30 par value;
1,800,000,000 shares authorized;
 Issued at September 30, 2013 -        304                306
1,013,111,000 ; December 31, 2012 -
1,020,057,000
Additional paid-in capital               11,007             10,655
Reinvested earnings                      17,020             14,383
Accumulated other comprehensive loss    (8,000)            (8,646)
Common stock held in treasury, at cost
(87,041,000 shares                       (6,727)            (6,727)
 at September 30, 2013 and December
31, 2012)
Total DuPont stockholders' equity        13,841             10,208
Noncontrolling interests                 59                 91
Total equity                             13,900             10,299
Total                                    $     51,990   $     49,859



E. I. du Pont de Nemours and Company

Condensed Consolidated Statement of Cash Flows

(Dollars in millions)
SCHEDULE A (continued)
                                          Nine Months Ended

                                          September 30,
Total Company                             2013              2012
Net income                                $     4,677  $     2,687
Adjustments to reconcile net income to
cash used for operating activities:
Depreciation                              961               1,047
Amortization                              255               266
Other operating charges and credits - net 447               907
Gain on sale of business                  (2,689)           -
Contributions to pension plans            (246)             (762)
Change in operating assets and            (5,738)           (4,571)
liabilities - net
Cash used for operating activities        (2,333)           (426)
Investing activities
Purchases of property, plant and          (1,223)           (1,139)
equipment
Investments in affiliates                 (43)              (31)
Payments for businesses - net of cash     (133)             (18)
acquired
Proceeds from sale of business - net      4,816             -
Proceeds from sales of assets - net      126               175
Net (increase) decrease in short-term     (78)              336
financial instruments
Forward exchange contract settlements     82                23
Other investing activities - net          31                (13)
Cash provided by (used for) investing     3,578             (667)
activities
Financing activities
Dividends paid to stockholders            (1,242)           (1,191)
Net increase in borrowings                3,204             2,524
Repurchase of common stock                (1,000)           (400)
Proceeds from exercise of stock options   497               520
Payments for noncontrolling interest      -                 (447)
Other financing activities - net          3                 38
Cash provided by financing activities     1,462             1,044
Effect of exchange rate changes on cash   (81)              (23)
Cash classified as held for sale          -                 (96)
Increase (decrease) in cash and cash      2,626             (168)
equivalents
Cash and cash equivalents at beginning of 4,379             3,586
period
Cash and cash equivalents at end of       $     7,005  $     3,418
period
Reconciliation of Non-GAAP Measure
Calculation of Free Cash Flow - Total
Company
                                          Nine Months Ended
                                          September 30,
                                          2013              2012
Cash used for operating activities        $    (2,333)  $      (426)
Purchases of property, plant and          (1,223)           (1,139)
equipment
Free cash flow                            $    (3,556)  $    (1,565)



E. I. du Pont de Nemours and Company

Schedule of Significant Items from Continuing Operations

(Dollars in millions, except per share amounts)
SCHEDULE B
SIGNIFICANT ITEMS FROM CONTINUING OPERATIONS
                             Pre-tax         After-tax        ($ Per Share)
                             2013    2012    2013     2012    2013     2012
1st Quarter
Customer claims charge ^(a)  $     $     $      $     $      $   
                             (35)   (50)   (22)    (32)   (0.02)  (0.04)
Income tax items ^(b)        -       -       42       -       0.04     -
1st Quarter - Total          $     $     $     $     $     $   
                             (35)   (50)   20      (32)   0.02    (0.04)
2nd Quarter
Customer claims charge ^(a)  $     $      $      $      $      $   
                             (80)   (265)  (51)    (169)  (0.05)  (0.18)
Income tax items ^(c)        (11)    -       (27)     -       (0.03)   -
Litigation settlement ^(d)   -       (137)   -        (123)   -        (0.13)
Gain on sale of equity       -       122     -        77      -        0.08
method investment ^(e)
2nd Quarter - Total          $     $      $      $      $      $   
                             (91)   (280)  (78)    (215)  (0.08)  (0.23)
3rd Quarter
Customer claims charge ^(a)  $     $      $      $     $      $   
                             (40)   (125)  (24)    (80)   (0.03)  (0.09)
Litigation settlement ^(f)   (72)    -       (47)     -       (0.05)   -
Restructuring charge ^(g)    -       (152)   -        (105)   -        (0.11)
Asset impairment charge ^(h) -       (242)   -        (157)   -        (0.17)
3rd Quarter - Total          $      $      $      $      $      $   
                             (112)  (519)  (71)    (342)  (0.08)  (0.37)
Year-to-date - Total ^(i)    $      $      $       $      $      $   
                             (238)  (849)  (129)   (589)  (0.14)  (0.63)

    Third quarter 2013 includes a net charge of $(40) consisting of a $(65)
    charge associated with the company's process to fairly resolve claims
    related to the use of Imprelis® herbicide offset by $25 of insurance
    recoveries. At September 30, 2013, the company has recorded charges of
    $(930) to resolve these claims. The company will continue to evaluate
    reported claim damage as additional information becomes available. It is
    reasonably possible that additional charges could result related to this
    matter and the company currently estimates that total charges could be
(a) about $1,200. The company has an applicable insurance program with a
    deductible equal to the first $100 of costs and expenses. The insurance
    program limits are $725 for costs and expenses in excess of the $100. The
    company has submitted and will continue to submit requests for payment to
    its insurance carriers for costs associated with this matter. The company
    has begun to receive payment from its insurance carriers and continues to
    seek recovery although the timing and outcome remain uncertain. These
    charges are recorded in Other operating charges and relate to the
    Agriculture segment.
    First quarter 2013 included a net tax benefit of $42 consisting of a $68
(b) benefit for the 2013 extension of certain U.S business tax provisions
    offset by a ($26) charge related to the global distribution of Performance
    Coatings cash proceeds.
    Second quarter 2013 included a charge of ($11) in Other income, net
    related to interest on a prior year tax position. Second quarter 2013
(c) also included a charge of ($49) associated with a change in accrual for a
    prior year tax position (inclusive of a benefit associated with interest
    on a prior year tax position) offset by a $33 benefit for an enacted tax
    law change.
    Second quarter 2012 included a charge of ($137) recorded in Other
(d) operating charges primarily related to the company's settlement of
    litigation with Invista. This matter relates to Other.
    Second quarter 2012 included a pre-tax gain of $122 recorded in Other
(e) income, net associated with the sale of an equity method investment in the
    Electronics & Communications segment.
    Third quarter 2013 includes a charge of $(72) recorded in Other operating
(f) charges related to the company's settlement of titanium dioxide antitrust
    litigation. This matter relates to the Performance Chemicals segment.
    Third quarter 2012 included a $152 restructuring charge recorded in
    Employee separation/asset related charges, net consisting of $133 of
    severance and related benefit costs and $19 of asset related charges as a
    result of the company's plan to eliminate corporate costs previously
(g) allocated to Performance Coatings and cost-cutting actions to improve
    competitiveness. Pre-tax charges by segment were: Agriculture - $(3),
    Nutrition & Health - $(13), Electronics & Communications - $(7),
    Performance Chemicals - $(3), Performance Materials - $(9), Safety &
    Protection - $(55), Industrial Biosciences - $(3), and Corporate expenses
    - $(59).
    Third quarter 2012 included a $242 impairment charge recorded in Employee
    separation/asset related charges, net related to asset groupings within
    the Electronics & Communications and Performance Materials segments. The
(h) charge of $150 within Electronics & Communications was a result of
    conditions within the thin film photovoltaic market. The charge of $92
    within Performance Materials was the result of deteriorating conditions in
    an industrial polymer market.
(i) Earnings per share for the year may not equal the sum of quarterly
    earnings per share due to changes in average share calculations.



E. I. du Pont de Nemours and Company

Consolidated Segment Information

(Dollars in millions)
SCHEDULE C
                            Three Months Ended      Nine Months Ended
                            September 30,           September 30,
SEGMENT SALES ^(1)          2013        2012        2013          2012
Agriculture                 $  1,633  $  1,423  $   9,933  $   8,891
Electronics &               638         607         1,907         2,079
Communications
Industrial Biosciences      305         292         898           880
Nutrition & Health          868         876         2,601         2,569
Performance Chemicals       1,720       1,732       5,087         5,600
Performance Materials       1,663       1,614       4,892         4,913
Safety & Protection         985         934         2,909         2,861
Other                       1           2           5             4
Total Segment sales         7,813       7,480       28,232        27,797
Elimination of transfers    (78)        (90)        (245)         (310)
Consolidated net sales      $  7,735  $  7,390  $  27,987   $  27,487
(1) Sales for the reporting segments include transfers.



E. I. du Pont de Nemours and Company

Consolidated Segment Information

(Dollars in millions)
SCHEDULE C (continued)
                                 Three Months Ended    Nine Months Ended
                                 September 30,         September 30,
INCOME/(LOSS) FROM CONTINUING    2013     2012         2013         2012
OPERATIONS (GAAP)
Agriculture                     $      $  (198)   $  2,240   $  1,772
                                 (102)
Electronics & Communications     97       (99)         241          181
Industrial Biosciences           45       37           129          118
Nutrition & Health               81       64           218          248
Performance Chemicals            182      410          697          1,575
Performance Materials            374      230          1,002        851
Safety & Protection              171      92           481          432
Pharmaceuticals                 5        10           27           53
Other                            (112)    (85)         (276)        (385)
Total Segment PTOI               741      461          4,759        4,845
Corporate expenses               (162)    (233)        (582)        (708)
Interest expense                 (108)    (116)        (340)        (347)
Non-operating pension/OPEB costs (142)    (157)        (415)        (507)
Net exchange gains (losses) ^(1) (101)    (130)        (55)         (161)
Income before income taxes from  $     $  (175)   $  3,367   $  3,122
continuing operations          228
                                 Three Months Ended    Nine Months Ended
                                 September 30,         September 30,
SIGNIFICANT ITEMS BY SEGMENT     2013     2012         2013         2012
(PRE-TAX) ^(2)
Agriculture                     $     $  (128)   $   (155)  $  (443)
                                 (40)
Electronics & Communications     -        (157)        -            (35)
Industrial Biosciences           -        (3)          -            (3)
Nutrition & Health               -        (13)         -            (13)
Performance Chemicals            (72)     (3)          (72)         (3)
Performance Materials            -        (101)        -            (101)
Safety & Protection              -        (55)         -            (55)
Pharmaceuticals                 -        -            -            -
Other                            -        -            -            (137)
Total significant items by       (112)    (460)        (227)        (790)
segment
Corporate expenses               -        (59)         (11)         (59)
Total significant items before   $      $  (519)   $   (238)  $  (849)
income taxes                     (112)
                                 Three Months Ended    Nine Months Ended
                                 September 30,         September 30,
OPERATING EARNINGS               2013     2012         2013         2012
Agriculture                     $     $   (70)  $  2,395   $  2,215
                                 (62)
Electronics & Communications     97       58           241          216
Industrial Biosciences           45       40           129          121
Nutrition & Health               81       77           218          261
Performance Chemicals            254      413          769          1,578
Performance Materials            374      331          1,002        952
Safety & Protection              171      147          481          487
Pharmaceuticals                 5        10           27           53
Other                            (112)    (85)         (276)        (248)
Total segment operating earnings 853      921          4,986        5,635
Corporate expenses               (162)    (174)        (571)        (649)
Interest expense                 (108)    (116)        (340)        (347)
Operating earnings before income
taxes and exchange gains         583      631          4,075        4,639
(losses)
Net exchange gains (losses) ^(1) (101)    (130)        (55)         (161)
Operating earnings before income $     $   501   $  4,020   $  4,478
taxes                            482
(1) See Schedule D for additional information on exchange gains and losses.
(2) See Schedule B for detail of significant items.



E. I. du Pont de Nemours and Company

Reconciliation of Non-GAAP Measures

(Dollars in millions, except per share amounts)
SCHEDULE D
Reconciliations of Adjusted EBIT / EBITDA to Consolidated Income Statements
                              Three Months Ended           Nine Months Ended
                              September 30,                September 30,
                              2013            2012         2013        2012
Income from continuing        $         $        $       $   
operations before income      228             (175)       3,367      
taxes                                                                  3,122
Add: Significant items before 112             519          238         849
income taxes
Add: Non-operating            142             157          415         507
pension/OPEB costs
Operating earnings before     $         $        $       $   
income taxes                  482             501        4,020      
                                                                       4,478
Less: Net income attributable 3               3            14          24
to noncontrolling interests
Add: Interest expense       108             116          340         347
Adjusted EBIT from operating  587             614          4,346       4,801
earnings
Add: Depreciation and         379             393          1,216       1,237
amortization
Adjusted EBITDA from          $         $        $       $   
operating earnings            966            1,007         5,562      
                                                                       6,038
Reconciliation of Operating Earnings Per Share (EPS) Outlook
The reconciliation below represents the company's outlook on an operating
earnings basis, defined as earnings from continuing operations excluding
significant items and non-operating pension/OPEB costs.
                              Year Ended December 31,
                              2013 Outlook    2012
                                              Actual
Operating EPS                 $         $    
                              3.85             3.77
Significant items
Tax items                     0.02            -
Sale of an equity method      -               0.08
investment
Customer claims charges       (0.11)          (0.39)
Restructuring                 -               (0.17)
charge/adjustments
Litigation settlement         (0.05)          (0.13)
Asset impairment charge       -               (0.19)
Sale of business              -               0.08
Non-operating pension/OPEB    (0.40)          (0.46)
costs - estimate
Impact of LIFO accounting     -               0.02
change
EPS from continuing           $         $    
operations (GAAP)             3.31             2.61



E. I. du Pont de Nemours and Company

Reconciliation of Non-GAAP Measures

(Dollars in millions)
SCHEDULE D (continued)
Exchange Gains/Losses on Operating Earnings
The company routinely uses forward exchange contracts to offset its net
exposures, by currency, related to the foreign currency denominated monetary
assets and liabilities of its operations. The objective of this program is to
maintain an approximately balanced position in foreign currencies in order to
minimize, on an after-tax basis, the effects of exchange rate changes. The net
pre-tax exchange gains and losses are recorded in Other income, net and the
related tax impact is recorded in Provision for (benefit from) income taxes on
the Consolidated Income Statements.
                                        Three Months Ended  Nine Months Ended

                                        September 30,       September 30,
                                        2013       2012     2013       2012
Subsidiary/Affiliate Monetary Position
Gain (Loss)
Pre-tax exchange gains (losses)         $       $     $        $   
(includes equity affiliates)             29        91    (121)      (50)
Local tax benefits (expenses)           13         (6)      32         10
Net after-tax impact from subsidiary    $       $     $       $   
exchange gains (losses)                  42        85    (89)       (40)
Hedging Program Gain (Loss)
Pre-tax exchange gains (losses)         $        $      $       $  
                                        (130)      (221)    66       (111)
Tax benefits (expenses)                 45         77       (24)       38
Net after-tax impact from hedging       $       $      $       $   
program exchange gains (losses)         (85)       (144)    42       (73)
Total Exchange Gain (Loss)
Pre-tax exchange gains (losses)         $        $      $       $  
                                        (101)      (130)   (55)       (161)
Tax benefits (expenses)                 58         71       8          48
Net after-tax exchange gains (losses)   $       $     $       $  
^(1)                                    (43)       (59)    (47)       (113)
As shown above, the "Total Exchange Gain (Loss)" is the sum of the
"Subsidiary/Affiliate Monetary Position Gain (Loss)" and the "Hedging Program
Gain (Loss)."
(1) The above Net after-tax exchange gains (losses) excludes gains (losses)
attributable to discontinued operations of $0 and $9 for the three months
ended September 30, 2013 and 2012, respectively, and $(5) and $(11) for the
nine months ended September 30, 2013 and 2012, respectively.



Reconciliation of Base Income Tax Rate to Effective Income
Tax Rate
Base income tax rate is defined as the effective income tax rate less the
effect of exchange gains (losses), as defined above, significant items and
non-operating pension/OPEB costs.
                                          Three Months Ended  Nine Months
                                                              Ended
                                          September 30,
                                                              September 30,
                                          2013       2012     2013     2012
Income from continuing operations before  $       $      $       $  
income taxes                             228        (175)   3,367   3,122
Add: Significant items - (benefit)      112        519      238      849
charge ^(2)
Non-operating pension/OPEB costs          142        157      415      507
Less: Net exchange (losses) gains        (101)      (130)    (55)     (161)
Income from continuing operations before
income taxes, significant items,
exchange
gains (losses), and non-operating         $       $     $       $  
pension/OPEB costs                        583        631     4,075   4,639
Provision for income taxes on continuing  $       $      $     $   
operations                                (35)       (135)   687      654
Add: Tax benefits (expenses) on          41         177      109      260
significant items
 Tax benefits (expenses) on      47         51       136      167
non-operating pension/OPEB costs
 Tax benefits (expenses) on      58         71       8        48
exchange gains/losses
Provision for income taxes on operating   $       $     $     $  
earnings, excluding exchange gains        111        164     940      1,129
(losses)
Effective income tax rate                 (15.4%)    77.1%    20.4%    20.9%
Significant items effect and              26.4%      (58.5%)  2.8%     3.2%
non-operating pension/OPEB costs effect
Tax rate, from continuing operations,
before significant items and              11.0%      18.6%    23.2%    24.1%
non-operating pension/OPEB costs
Exchange gains (losses) effect            8.0%       7.4%     (0.1%)   0.2%
Base income tax rate from continuing      19.0%      26.0%    23.1%    24.3%
operations
(2) See Schedule B for detail of significant items.



SOURCE DuPont

Website: http://www.dupont.com
Contact: Media Contact: Patty Seif, 302-774-4482, patricia.r.seif@dupont.com
or Investor Contact: 302-774-4994
 
Press spacebar to pause and continue. Press esc to stop.